KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Cash from Operations (2016 - 2026)

Esperion Therapeutics filings provide 8 years of Cash from Operations readings, the most recent being 45243000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 229.44% to 45243000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 13093000.0, a 44.65% increase, with the full-year FY2025 number at 13093000.0, up 44.65% from a year prior.
  • Cash from Operations hit 45243000.0 in Q4 2025 for Esperion Therapeutics, up from 4286000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 53828000.0 in Q1 2024 to a low of 89068000.0 in Q1 2021.
  • Median Cash from Operations over the past 5 years was 36190500.0 (2023), compared with a mean of 30543500.0.
  • The widest YoY moves for Cash from Operations: up 229.44% in 2025, down 336.11% in 2025.
  • Esperion Therapeutics' Cash from Operations stood at 57706000.0 in 2021, then rose by 26.4% to 42472000.0 in 2022, then grew by 12.75% to 37056000.0 in 2023, then rose by 5.68% to 34952000.0 in 2024, then skyrocketed by 229.44% to 45243000.0 in 2025.
  • The last three reported values for Cash from Operations were 45243000.0 (Q4 2025), 4286000.0 (Q3 2025), and 31422000.0 (Q2 2025) per Business Quant data.